$1.66
7.26% yesterday
NYSE, Apr 03, 10:14 pm CET
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Nuvation Bio Inc - Ordinary Shares - Class A Stock price

$1.66
-0.16 8.79% 1M
-0.68 29.06% 6M
-1.00 37.59% YTD
-1.97 54.27% 1Y
-3.99 70.62% 3Y
-8.34 83.40% 5Y
-8.34 83.40% 10Y
NYSE, Closing price Thu, Apr 03 2025
-0.13 7.26%
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Key metrics

Market capitalization $606.24m
Enterprise Value $112.47m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 14.29
P/S ratio (TTM) P/S ratio 77.03
P/B ratio (TTM) P/B ratio 1.30
Revenue (TTM) Revenue $7.87m
EBIT (operating result TTM) EBIT $-167.56m
Free Cash Flow (TTM) Free Cash Flow $-130.58m
Cash position $502.69m
EPS (TTM) EPS $-2.25
P/E forward negative
P/S forward 18.10
EV/Sales forward 3.36
Short interest 11.73%
Show more

Is Nuvation Bio Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Nuvation Bio Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

Buy
100%

Financial data from Nuvation Bio Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
7.87 7.87
-
100%
- Direct Costs 7.76 7.76
3,984% 3,984%
99%
0.11 0.11
158% 158%
1%
- Selling and Administrative Expenses 68 68
141% 141%
862%
- Research and Development Expense 99 99
39% 39%
1,259%
-167 -167
67% 67%
-2,120%
- Depreciation and Amortization 0.68 0.68
258% 258%
9%
EBIT (Operating Income) EBIT -168 -168
68% 68%
-2,129%
Net Profit -568 -568
649% 649%
-7,217%

In millions USD.

Don't miss a Thing! We will send you all news about Nuvation Bio Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuvation Bio Inc - Ordinary Shares - Class A Stock News

Neutral
Business Wire
one day ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in a fireside chat at the Jones Healthcare and Technology Innova...
Neutral
Business Wire
9 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that new nonclinical data for taletrectinib in ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC) will be presented at the American Association for Cancer Research (AACR) Annual Meeting taking place April 25–30, 2025 in Chicag...
Neutral
Business Wire
9 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that new data from a matching-adjusted indirect comparison study evaluating taletrectinib versus crizotinib in ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC) will be reported in a mini oral presentation at the European Lun...
More Nuvation Bio Inc - Ordinary Shares - Class A News

Company Profile

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Head office United States
CEO David Hung
Employees 220
Founded 2018
Website www.nuvationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today